OptoVAX is a novel platform technology for the production of live attenuated vaccines.
Supported by:
GoBio initial - German Federal Institute for Education and Research (BMBF)
Profund Innovation
Freie Universität Berlin
Company Details
- Employees
- 2
- Address
- Berlin, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.optovax.com
- Keywords
- Vaccines, Infectious Diseases, Immunology.
- HQ
- Berlin
Optovax Questions
Optovax's website is http://www.optovax.com
Optovax's LinkedIn profile is https://de.linkedin.com/company/optovax
Optovax has
2 employees.
View email and phone details for 2
employees at Optovax.
Optovax's industry is
Biotechnology Research
Optovax's top competitors are
Microbiome Network Berlin-Brandenburg,
Cistim,
Tgc Health,
Aai Media,
Flemingo,
Grit Biotechnology,
Twist Bioscience,
De.nbi,
Milkyv,
Kryoni.
Optovax's categories are Biotechnology Research
